Disruption of CDK5 regulatory subunit 1, p35, limits immunosuppressive M2 macrophages while maintaining functional M1

Juliana R Zampieri1, Sung Hee Choi2,3, Jay T Myers2

  • 1Faculdade Israelita de Ciências da Saúde Albert Einstein Hospital Israelita Albert Einstein, São Paulo, Brazil.

Frontiers in Immunology
|October 3, 2025
PubMed
Abstract

Insights

The p35 protein is crucial for macrophage metabolism and antigen processing, impacting M1 and M2 polarization. Its absence alters glycolysis, oxidative phosphorylation, and antigen presentation, suggesting therapeutic potential.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophage polarization into M1 and M2 phenotypes is critical for immune responses.
  • Cyclin-Dependent Kinase 5 (CDK5) is implicated in cellular processes, requiring regulatory subunits like p35 for activation.

Purpose of the Study:

  • To investigate the specific role of the p35 protein in regulating macrophage polarization to M1 and M2 phenotypes.
  • To understand how p35 influences macrophage metabolism and antigen processing during polarization.

Main Methods:

  • Comparison of bone marrow-derived macrophages from wild-type and p35 knockout mice.
  • Assessment of M1 (IFNγ + LPS) and M2 (IL4) polarization markers, including surface markers (CD86, CD206) and enzyme expression (Arginase-1, iNOS).
  • Analysis of macrophage metabolism, antigen processing, and presentation capabilities.

Main Results:

  • p35 deficiency led to decreased Arginase-1 production and STAT3 phosphorylation, particularly after M2 polarization.
  • Absence of p35 increased glycolysis in M1 polarization and enhanced mitochondrial oxidative phosphorylation in M2 polarization.
  • p35 was essential for efficient antigen processing and peptide: MHC II complex stability, especially in M0 and M2 macrophages, though M1 macrophages showed reduced complex stability.

Conclusions:

  • The p35 protein plays a vital role in regulating macrophage metabolism and antigen processing functions.
  • Loss of p35 significantly impairs antigen presentation capacity, with distinct effects on M1, M2, and naive M0 macrophages.
  • These findings highlight p35 as a potential therapeutic target for modulating immune responses.